BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
110.23
+1.43 (1.31%)
At close: Feb 27, 2026, 4:00 PM EST
111.00
+0.77 (0.70%)
After-hours: Feb 27, 2026, 6:00 PM EST
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $27.66 billion as of February 27, 2026. Its market cap has increased by 3.12% in one year.
Market Cap
27.66B
Enterprise Value
10.90B
1-Year Change
3.12%
Ranking
Category
Stock Price
$110.23
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $27.66B, an increase of 823.55%. That is a compound annual growth rate of 41.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 27.66B | 20.83% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.07B |
| Alnylam Pharmaceuticals | 43.93B |
| BeOne Medicines AG | 35.76B |
| Insmed | 32.33B |
| Royalty Pharma | 26.17B |
| Moderna | 20.42B |
| Roivant Sciences | 20.39B |
| Revolution Medicines | 20.12B |